FDA Drug Recalls

Recalls / Class II

Class IID-0337-2024

Product

Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the bottle to release the powder. Add 50mL of water to the bottle and shake vigorously for 1 minute. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202. NDC: 43386-038-60.

Brand name
Voriconazole
Generic name
Voriconazole
Active ingredient
Voriconazole
Route
Oral
NDC
43386-038
FDA application
ANDA206799
Affected lot / code info
Lot#: S200756; Exp. 10/2024 Lot#: S300218; Exp. 04/2025 Lot#: S300633; Exp. 09/2025

Why it was recalled

Labeling: Incorrect or Missing Package Insert

Recalling firm

Firm
Lupin Pharmaceuticals Inc.
Manufacturer
Lupin Pharmaceuticals,Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
Harborplace Tower, 111 S Calvert St Fl 21st, Baltimore, Maryland 21202-6174

Distribution

Quantity
N/A
Distribution pattern
OH, IL, NJ

Timeline

Recall initiated
2024-02-05
FDA classified
2024-02-16
Posted by FDA
2024-02-28
Terminated
2024-12-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0337-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Voriconazole · FDA Drug Recalls